The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding

Life Sciences

Volumn 61, Issue 20, 1997, Pages 1993-1998

  Paul, Dennis ^a,c   Gauthier, Cheryl A ^a   Minor, Lerna D ^a   Gonzales, Gilbert R ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Opioid receptor; Postmortem degradation; Postmortem receptor subtype binding; Radioligand receptor binding

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CADAVER; CEREBELLUM; CONTROLLED STUDY; GUINEA PIG; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; RECEPTOR BINDING;

ANIMALS; BENZENEACETAMIDES; BRAIN; CEREBELLUM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE-2-ALANINE; ENKEPHALINS; GUINEA PIGS; KINETICS; MALE; NALOXONE; POSTMORTEM CHANGES; PYRROLIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TRITIUM;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030842222     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00857-6     Document Type: Article

References (15)

1. G.R. GONZALES and D. PAUL, Analgesia 2 103-106 (1996).
2. M.J. KUHAR, C.B. PERT, S.H. SNYDER, Nature 245 447-45 (1973).
3. P.J. WHITEHOUSE, D. LYNCH, M.J. KUHAR, J. Neurochem 43 553-559 (1984).
4. E.D. BIRD, Neurosecretions in Brain Peptides, J.B. Martin, S. Reichlin; K.L. Bick (Eds), 657-671, Raven Press, New York (1981).
5. P. DAVIES, S. FEISULLIN, Brain Res. 216 449-454 (1981).
6. S.J. ENNA, E.D. BIRD, J.P. BENNET, D.B. BYLUND, H.I. YAMAMURA, L.L. IVERSEN, S.H. SNYDER, N.E.J.M. 294 1305-1309 (1976).
7. T.D. REISINE, J.Z. FIELDS, H.I. YAMAMURA, E.D. BIRD, E. SPOKES, P.S. SCHREINER, S.J. ENNA, Life Sci. 21 335-344 (1977).
8. E.K. PERRY, P.H. GIBSON, G. BLESSED, R.H. PERRY, B.E. TOMLINSON, J. Neurol. Sci. 34 247-265 (1977).
9. U.K. RINNE, V. KOSKINEN, V. LAAKSONEN, P. LONNBERG, V. SONNINEN, Life Sci. 22 2225-2228 (1978).
10. J.A. CLARK, R. HOUGHTEN, G.W. PASTERNAK, Mol. Pharmacol. 34 308-317 (1988).
11. M.A. YAMAMURA, R. HORVATH, G. TOTH, F. OTVOS, E. MALATYNSKA, R.J. KNAPP, F. PORRECA, V.J. HRUBY, H.I. YAMAMURA, Life Sci. 50 PL119-124 (1992).
12. J.A. CLARK, L. LIU, M. PRICE, B. HERSH, M. EDELSON, G.W. PASTERNAK, J. Pharmacol. Exp. Ther. 251 461-468 (1989).
13. H.W. KOSTERLITZ, S.J. PATERSON, L.E. ROBSON, Br. J. Pharmacol. 73 939-942 (1981).
14. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR, R.J. RANDALL, J. Biol. Chem. 193 265-267 (1951).
15. K.G. LLOYD and S. DREKSLER, Brain Res. 163 77-87 (1979).